世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

自己輸血システム市場:タイプ毎(製品、アクセサリ)、用途毎(心臓手術、整形外科手術、臓器移植、外傷、その他) - 2024年までの世界市場予測

Autotransfusion Systems Market by Type (Autotransfusion Products & Accessories) and Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures) - Global Forecast to 2024

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年8月US$5,650
シングルユーザライセンス
116 94

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の自己輸血システム市場に関する調査レポートです。

“The autotransfusion systems market is projected to grow at a CAGR of 5.0%.”

The autotransfusion systems market is projected to reach USD 505 million by 2024 from USD 395 million in 2019, at a CAGR of 5.0%. The growth of this market is driven by the increasing number of surgical procedures, rising number of transplant procedures, advantages of autotransfusion, and scarcity of donated blood/allogenic blood.

 “The autotransfusion products segment is expected to witness the highest growth in the autotransfusion systems market during the forecast period.”

On the basis of type, the autotransfusion systems market is segmented into autotransfusion products & autotransfusion accessories. The autotransfusion products segment is estimated to grow at the highest CAGR during the forecast period owing to a number of advantages, which is expected to boost its adoption in the coming years. These components prevent the transmission of transfusion-related blood-borne diseases in patients, and they also provide more compatible blood than in the case of autologous blood transfusions. These advantages are likely to increase the demand for autotransfusion products.

 “The cardiac surgeries segment, by application, is expected to witness the highest growth during the forecast period.”

On the basis of application, the autotransfusion systems market is segmented into Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Other Procedures. The Cardiac Surgeries segment is estimated to grow at the highest rate during the forecast period due to the high prevalence of cardiac diseases and recommendations for autologous transfusion (by entities such as the WHO) during cardiac surgeries.

“Asia Pacific is expected to grow at the highest CAGR in the market, by region, during the forecast period.”

Growth in this market segment is primarily due to the presence of a large target patient population in countries such as China and India, improving healthcare infrastructure, rising healthcare spending, increasing per capita income, and rising focus of key market players in strengthening their presence in several Asia Pacific countries.

Breakdown of supply-side primary interviews:

- By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
- By Designation: C-level (26%), Director-level (30%), and Others (44%)
- By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the global autotransfusion systems market are
Medtronic Plc (Ireland), Becton, Dickinson and Company (US), Zimmer Biomet Holdings, Inc (US), Teleflex Incorporated (US), LivaNova (UK), Fresenius (Germany), Atrium Medical Corporation (Sweden), Haemonetics Corporation (US), SARSTEDT (Germany), Braile Biom-dica (Brazil), Redax (Italy), Beijing ZKSK Technology Co (China), and Gen World Medical Devices (India) are some of the leading players.

Research Coverage

This report studies the autotransfusion systems market by type, application, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions-North America, Europe, Asia Pacific, and the Rest of the World.

Reasons to Buy the Report:

From an insights perspective, this research report focuses on various levels of analysis-market ranking the analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the autotransfusion systems market and high-growth regions and their drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY USED FOR THE STUDY 16
1.5 MARKET STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH APPROACH 17
2.1.1 SECONDARY SOURCES 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY SOURCES 19
2.1.2.1 Key data from primary sources 19
2.2 MARKET SIZE ESTIMATION 21
2.2.1 PRODUCT-BASED MARKET ESTIMATION 21
2.2.2 PRIMARY RESEARCH VALIDATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 29
4.1 AUTOTRANSFUSION SYSTEMS: MARKET OVERVIEW 29
4.2 AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY TYPE 30
4.3 AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2019 VS. 2024 (USD MILLION) 30
4.4 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION 31

5 MARKET OVERVIEW 32
5.1 MARKET DYNAMICS 32
5.1.1 DRIVERS 33
5.1.1.1 Increasing number of surgical procedures 33
5.1.1.2 Rising number of transplant procedures 33
5.1.1.3 Advantages of autotransfusion 34
5.1.1.4 Scarcity of donated blood/allogenic blood 35
5.1.2 RESTRAINTS 35
5.1.2.1 High costs associated with autotransfusion systems 35
5.1.2.2 Risks associated with autotransfusion 36
5.1.2.3 Government initiatives to streamline the allogenic/donated blood supply 36
5.1.3 OPPORTUNITIES 36
5.1.3.1 Emerging economies offer high growth potential 36
5.1.4 CHALLENGES 37
5.1.4.1 Scarcity of resources such as well-trained perfusionists and surgical technicians in developing countries 37
5.1.5 MARKET TRENDS 37
5.1.5.1 Development of low-cost autotransfusion devices 37

6 AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE 38
6.1 INTRODUCTION 39
6.2 AUTOTRANSFUSION PRODUCTS 39
6.2.1 AUTOTRANSFUSION PRODUCTS MARKET SPLIT, BY APPLICATION,
2017-2024 (USD MILLION) 41
6.2.2 INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS 41
6.2.2.1 Advantages of intraoperative blood autotransfusion to drive the growth of this segment 41
6.2.2.2 Intraoperative autotransfusion systems market split, by application, 2017-2024 (USD million) 42
6.2.3 POSTOPERATIVE AUTOTRANSFUSION SYSTEMS 43
6.2.3.1 Postoperative autotransfusion systems have wide usage in trauma procedures 43
6.2.3.2 Postoperative autotransfusion systems market split, by application, 2017-2024 (USD million) 44
6.2.4 DUAL-MODE AUTOTRANSFUSION SYSTEMS 44
6.2.4.1 Dual-mode autotransfusion systems have major applications in treatment procedures for massive trauma and malignant surgeries 44
6.2.4.2 Dual-mode autotransfusion systems market split, by application, 2017-2024 (USD million) 45
6.3 AUTOTRANSFUSION ACCESSORIES 45
6.3.1 AUTOTRANSFUSION ACCESSORIES MARKET SPLIT, BY APPLICATION,
2017-2024 (USD MILLION) 46

7 AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION 47
7.1 INTRODUCTION 48
7.2 CARDIAC SURGERIES 49
7.2.1 CARDIAC SURGERIES FORM THE LARGEST APPLICATION SEGMENT IN THE AUTOTRANSFUSION SYSTEMS MARKET 49
7.3 ORTHOPEDIC SURGERIES 50
7.3.1 RISING NUMBER OF ORTHOPEDIC PROCEDURES WILL SUPPORT MARKET GROWTH 50
7.4 ORGAN TRANSPLANTATION 51
7.4.1 RISING DISEASE PREVALENCE AND NEED FOR ORGAN DONATIONS WILL DRIVE DEMAND FOR AUTOTRANSFUSION SYSTEMS 51
7.5 TRAUMA PROCEDURES 52
7.5.1 HIGH LEVELS OF BLOOD LOSS IN TRAUMA PROCEDURES WILL SUPPORT USE OF AUTOTRANSFUSION SYSTEMS 52
7.6 OTHER PROCEDURES 53

8 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION 54
8.1 INTRODUCTION 55
8.2 NORTH AMERICA 57
8.2.1 US 60
8.2.1.1 Rising number of transplant procedures in the US to drive market growth 60
8.2.2 CANADA 61
8.2.2.1 Rising concerns over the risks associated with homologous blood transfusion to support market growth in Canada 61
8.3 EUROPE 63
8.3.1 GERMANY 65
8.3.1.1 Significant healthcare spending in the country to support market growth 65
8.3.2 FRANCE 66
8.3.2.1 Growing awareness and support for organ donation to propel the growth of the autotransfusion systems market in France 66
8.3.3 UK 68
8.3.3.1 Increasing number of transplantation procedures in the UK to drive market growth 68
8.3.4 REST OF EUROPE 69
8.4 ASIA PACIFIC 71
8.4.1 JAPAN 73
8.4.1.1 Rising geriatric population and universal healthcare coverage-major factors driving market growth in Japan 73
8.4.2 CHINA 74
8.4.2.1 Scarcity of donated blood to drive the adoption of autologous blood transfusion in China 74
8.4.3 INDIA 76
8.4.3.1 Presence of a large patient population and growing access to healthcare driving market growth in India 76
8.4.4 REST OF ASIA PACIFIC 77
8.5 REST OF THE WORLD 79
8.5.1 LATIN AMERICA 81
8.5.2 MIDDLE EAST 82
8.5.3 AFRICA 83
-
9 COMPETITIVE LANDSCAPE 85
9.1 INTRODUCTION 85
9.2 MARKET RANKING ANALYSIS 85
9.3 COMPETITIVE SCENARIO 86
9.3.1 ACQUISITIONS 86
9.3.2 AGREEMENTS 86
9.4 COMPETITIVE LEADERSHIP MAPPING 86
9.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2017) 86
9.4.1.1 Visionary leaders 87
9.4.1.2 Innovators 87
9.4.1.3 Dynamic players 87
9.4.1.4 Emerging companies 87

10 COMPANY PROFILES 89
(Business overview, Products offered, Recent developments & MnM View)*
10.1 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP) 89
10.2 BECTON, DICKINSON AND COMPANY 90
10.3 BEIJING ZKSK TECHNOLOGY CO., LTD. 92
10.4 BRAILE BIOM-DICA 93
10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA 94
10.6 GEN WORLD MEDICAL DEVICES 96
10.7 HAEMONETICS CORPORATION 97
10.8 LIVANOVA PLC 99
10.9 MEDTRONIC PLC 101
10.10 REDAX 103
10.11 SARSTEDT AG & CO. KG 104
10.12 TELEFLEX INCORPORATED 105
10.13 ZIMMER BIOMET HOLDINGS INC. 107
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

11 APPENDIX 109
11.1 DISCUSSION GUIDE 109
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 112
11.3 AVAILABLE CUSTOMIZATIONS 114
11.4 RELATED REPORTS 114
11.5 AUTHOR DETAILS 115

 

LIST OF TABLES

TABLE 1 AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 39
TABLE 2 AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE, 2017-2024 (USD MILLION) 40
TABLE 3 AUTOTRANSFUSION PRODUCTS MARKET, BY REGION, 2017-2024 (USD MILLION) 40
TABLE 4 AUTOTRANSFUSION PRODUCTS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 41
TABLE 5 INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION,
2017-2024 (USD MILLION) 42
TABLE 6 INTRAOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 42
TABLE 7 POSTOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION,
2017-2024 (USD MILLION) 43
TABLE 8 POSTOPERATIVE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 44
TABLE 9 DUAL-MODE AUTOTRANSFUSION SYSTEMS MARKET, BY REGION,
2017-2024 (USD MILLION) 45
TABLE 10 DUAL-MODE AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 45
TABLE 11 AUTOTRANSFUSION ACCESSORIES MARKET, BY REGION,
2017-2024 (USD MILLION) 46
TABLE 12 AUTOTRANSFUSION ACCESSORIES MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 46
TABLE 13 AUTOTRANSFUSION SYSTEMS (ATS) MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 48
TABLE 14 AUTOTRANSFUSION SYSTEMS MARKET FOR CARDIAC SURGERIES,
BY REGION, 2017-2024 (USD MILLION) 49
TABLE 15 AUTOTRANSFUSION SYSTEMS MARKET FOR ORTHOPEDIC SURGERIES,
BY REGION, 2017-2024 (USD MILLION) 50
TABLE 16 REQUIRED UNITS OF BLOOD AND BLOOD COMPONENTS,
BY TYPE OF TRANSPLANT SURGERY 51
TABLE 17 AUTOTRANSFUSION SYSTEMS MARKET FOR ORGAN TRANSPLANTATION,
BY REGION, 2017-2024 (USD MILLION) 51
TABLE 18 AUTOTRANSFUSION SYSTEMS MARKET FOR TRAUMA PROCEDURES, BY REGION, 2017-2024 (USD MILLION) 52
TABLE 19 AUTOTRANSFUSION SYSTEMS MARKET FOR OTHER PROCEDURES, BY REGION, 2017-2024 (USD MILLION) 53
TABLE 20 TOTAL NUMBER OF SOLID ORGAN TRANSPLANTATION PROCEDURES ACROSS
KEY COUNTRIES (2016) 55
TABLE 21 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION) 56
TABLE 22 NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY,
2017-2024 (USD MILLION) 58
TABLE 23 NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 58
TABLE 24 NORTH AMERICA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 59
TABLE 25 NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 59
TABLE 26 US: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 61
TABLE 27 US: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 61
TABLE 28 CANADA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 62
TABLE 29 CANADA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 63
TABLE 30 EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY,
2017-2024 (USD MILLION) 63
TABLE 31 EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 64
TABLE 32 EUROPE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 64
TABLE 33 EUROPE: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 65
TABLE 34 GERMANY: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 66
TABLE 35 GERMANY: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 66
TABLE 36 FRANCE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 67
TABLE 37 FRANCE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 67
TABLE 38 ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN THE UK, 2013 VS. 2015 68
TABLE 39 UK: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 68
TABLE 40 UK: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 69
TABLE 41 ROE: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION) 70
TABLE 42 ROE: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 70
TABLE 43 APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY COUNTRY,
2017-2024 (USD MILLION) 72
TABLE 44 APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 72
TABLE 45 APAC: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 72
TABLE 46 APAC: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 73
TABLE 47 JAPAN: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 74
TABLE 48 JAPAN: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 74
TABLE 49 CHINA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 75
TABLE 50 CHINA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 75
TABLE 51 INDIA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 76
TABLE 52 INDIA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 77
TABLE 53 SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED
IN ROAPAC COUNTRIES, 2013 VS. 2016 78
TABLE 54 ROAPAC: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 78
TABLE 55 ROAPAC: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 78
TABLE 56 ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY REGION,
2017-2024 (USD MILLION) 79
TABLE 57 ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 79
TABLE 58 ROW: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 80
TABLE 59 ROW: AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 80
TABLE 60 LATAM: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 81
TABLE 61 LATAM: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 81
TABLE 62 MIDDLE EAST: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 82
TABLE 63 MIDDLE EAST: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 83
TABLE 64 AFRICA: AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE,
2017-2024 (USD MILLION) 83
TABLE 65 AFRICA: AUTOTRANSFUSION PRODUCTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 84

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 20
FIGURE 4 PRODUCT-BASED MARKET SIZE ESTIMATION: AUTOTRANSFUSION SYSTEM MARKET 21
FIGURE 5 APPLICATION-BASED MARKET SIZE ESTIMATION: AUTOTRANSFUSION
SYSTEMS MARKET 22
FIGURE 6 DATA TRIANGULATION 24
FIGURE 7 AUTOTRANSFUSION SYSTEMS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 26
FIGURE 8 AUTOTRANSFUSION SYSTEMS MARKET, BY APPLICATION,
2019 VS. 2024 (USD MILLION) 27
FIGURE 9 AUTOTRANSFUSION SYSTEMS MARKET, BY REGION, 2019-2024 28
FIGURE 10 RISING NUMBER OF TRANSPLANT PROCEDURES GLOBALLY IS A KEY DRIVER
FOR MARKET GROWTH 29
FIGURE 11 AUTOTRANSFUSION PRODUCTS HELD THE LARGEST SHARE OF
THE MARKET IN 2018 30
FIGURE 12 CARDIAC SURGERIES DOMINATED THE AUTOTRANSFUSION SYSTEMS MARKET,
BY APPLICATION 30
FIGURE 13 APAC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 31
FIGURE 14 AUTOTRANSFUSION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 32
FIGURE 15 NUMBER OF KIDNEY TRANSPLANT PROCEDURES, BY COUNTRY, 2015 VS. 2018 34
FIGURE 16 NORTH AMERICA: AUTOTRANSFUSION SYSTEMS MARKET SNAPSHOT 57
FIGURE 17 SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN THE US,
2013-2017 60
FIGURE 18 SOLID-ORGAN TRANSPLANTATION PROCEDURES PERFORMED IN CANADA,
2015 VS. 2016 62
FIGURE 19 ASIA PACIFIC: AUTOTRANSFUSION SYSTEMS MARKET SNAPSHOT 71
FIGURE 20 AUTOTRANSFUSION SYSTEMS MARKET RANKING, BY KEY PLAYER, 2018 85
FIGURE 21 AUTOTRANSFUSION SYSTEMS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 88
FIGURE 22 GETINGE GROUP: COMPANY SNAPSHOT 89
FIGURE 23 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 90
FIGURE 24 FRESENIUS GROUP: COMPANY SNAPSHOT 94
FIGURE 25 HAEMONETICS CORPORATION: COMPANY SNAPSHOT 97
FIGURE 26 LIVANOVA PLC: COMPANY SNAPSHOT 99
FIGURE 27 MEDTRONIC PLC: COMPANY SNAPSHOT 101
FIGURE 28 TELEFLEX INCORPORATED: COMPANY SNAPSHOT 105
FIGURE 29 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT 107

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る